Learning Objectives:

1) List the pulmonary manifestations of SLE

2) Compare and contrast alveolar hemorrhage seen in rheumatic and non-rheumatic diseases

3) Discuss the management of SLE-related DAH

4) Explain the role of Rituximab in refractory DAH

Location: 
Duke South 3rd Floor Conference Room (purple zone)
200 Trent Drive
Durham, NC 27710
United States
Session date: 
01/26/2016 - 8:00am to 9:00am EST

Please login or register to take this course.
Room Number: 
3031
Speaker Name: 
Dr. Jason Weiner